Translate page

* indicates required

NICE Guidance on the use of imatinib 

NICE - National Institute for Health and Care Excellence
Guidance on the use of imatinib for chronic myeloid leukaemia
Issued October 2003; last modified January 2016

Click here to view the NICE guidance

ESMO Guidelines

Chronic Myeloid Leukemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Hochhaus A et al. Ann Oncol 2017 1;28(suppl_4): iv41-iv51

Click here to view the full publication

NCCN Guidelines 

Chronic Myelogenous Leukemia
National Comprehensive Cancer Network
Version 1.2019
Radich J et al. J Natl Compr Canc Netw 2018 Sept;16(09):1008-1135

Click here to view the NCCN Guidelines

Once registered you will get a copy of the guidelines for your personal use only.

International BFM Group (iBFM):
Managing children with CML

Managing children with chronic myeloid leukaemia (CML)
Recommendations for the management of CML in children and young people up to the age of 18 years
De la Fuente J et al. Br J of Haematol 2014;167:33-47.

Click here to view the full publication here 

ELN Recommendations

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Hochhaus A et al. Leukemia 2020;34(4):966-984

Click here to see the 2020 recommendations